All Resolutions Passed at 32nd AGM Held on 29 September 2026

At the 32nd AGM (29 Sep 2026), shareholders passed all resolutions: FY26 accounts adopted, Mr. Ram Niwas Sharma re-appointed as Non-Executive Director, Nemani Garg Agarwal & Co. re-appointed Statutory Auditors for 5 years.

Thu 1 Oct 2026

AGM Date

29 September 2026

Auditor Re-appointment Term

5 consecutive years, from 32nd AGM until 37th AGM

Independent Director Appointment Term

5 consecutive years, from 32nd AGM up to 37th AGM to be held in 2031

Independent Director Name

Ms. Anchal Goyal

What happened

The company (formerly Advik Laboratories Limited, now MPS Pharmaa Limited) held its 32nd Annual General Meeting on Tuesday, 29 September 2026 at 09.30 A.M. at its registered office in Sohna, Haryana. Based on the Scrutinizer's report dated 30 September 2026 from M/s Kundan Agrawal & Associates, all resolutions were passed with the requisite majority.

Resolutions approved

• Adoption of audited financial statements for the financial year ended 31st March, 2026, with Board and Auditors' reports.
• Re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director liable to retire by rotation.
• Re-appointment of M/s Nemani Garg Agarwal & Co. as Statutory Auditors for a second term of 05 consecutive years, from the 32nd AGM until the 37th AGM.
• Appointment of Ms. Anchal Goyal as an Independent Director for 5 consecutive years, from the 32nd AGM up to the 37th AGM to be held in 2031.
• Approval of Related Party Transactions under Section 188 of the Companies Act, 2013 and Regulation 23 of SEBI LODR.
• Approval for transactions under Section 185 of the Companies Act, 2013.

About the appointees

Mr. Ram Niwas Sharma has more than two decades of experience in the corporate sector including stock broking, marketing and general administration. Ms. Anchal Goyal is an MCA post-graduate with more than 12 years of experience in IT management, marketing and general administration.

What it means for investors

This is a routine governance outcome confirming shareholder approval of the year's standard business items, board continuity and auditor continuity.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.